graphic
News > Deals
P&G ups Regeneron stake
June 1, 2000: 10:50 a.m. ET

Procter & Gamble boosts stake in drug maker to 16% in $17 million sale
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Procter & Gamble will boost its stake in Regeneron Pharmaceuticals to 16 percent in a deal valued at $17 million, Regeneron announced Thursday.

The sale of the 573,630 shares, or the 1.3 percent stake, is at a per-share price of $29.75: in compliance with a deal made in 1997 that called for the sale of $17 million in Regeneron common stock to Procter & Gamble. The sale is expected to close in August.

The per-share price of the deal is at a premium to Thursday's market price for Regeneron shares at $23.25. The $29.75 share price is the same price Regeneron's stock sold for in a public offering last year.

After the deal, Procter & Gamble (PG: Research, Estimates) will own a total of about 5.7 million shares of Regeneron (REGN: Research, Estimates). Procter & Gamble, a consumer products company based in Cincinnati, also has warrants to purchase an additional 1.45 million shares.

graphicTarrytown, N.Y.-based Regeneron is a pharmaceutical company that develops therapeutic drugs for the treatment of serious diseases.

In early morning trading Thursday, Regeneron's shares rose 2-7/8 to 23-1/4 while Procter & Gamble fell 5/16 to 66-3/16. Back to top

  RELATED SITES

Procter & Gamble

Regeneron


Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.